# TNFSF11 Inhibition and Fertility: a Prospective Study

> **NCT02422108** · PHASE2 · COMPLETED · sponsor: **Martin Blomberg Jensen** · enrollment: 12 (actual)

## Conditions studied

- Testis
- Infertility
- Sperm

## Interventions

- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT02422108
- **Lead sponsor:** Martin Blomberg Jensen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-02
- **Final completion:** 2019-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02422108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02422108, "TNFSF11 Inhibition and Fertility: a Prospective Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02422108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*